Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
(NY:
ALUR
)
1.590
-0.040 (-2.45%)
Streaming Delayed Price
Updated: 10:23 AM EDT, May 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about ALUR
Allurion Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean Mass Preservation for Sustainable, Healthy Weight Loss
May 15, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Reports First Quarter 2024 Financial Results and Provides Business Update
May 14, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Announces Three Scientific Presentations at IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance Survey
May 02, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Announces Preliminary First Quarter 2024 Results
April 30, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Closes $48 Million Convertible Senior Secured Note Financing with RTW Investments
April 17, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Expands Virtual Care Suite to the United States
April 04, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
March 21, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
March 13, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Milena Alberti-Perez Joins Allurion Board of Directors as Audit Committee Chair
March 12, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion to Report Fourth Quarter 2023 Financial Results on March 21, 2024
March 04, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion to Participate in Cowen’s 44th Annual Health Care Conference
February 20, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference
February 08, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Brendan Gibbons Appointed Chief Legal Officer at Allurion Technologies
January 29, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Somerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight Loss
January 23, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion's Virtual Care Suite Digital Platform Accelerates Commercial Expansion With New Strategic Partnerships
January 17, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Announces Publication of Randomized, Double-Blind Study Demonstrating Significant Improvement in Obesity-Related Co-Morbidities
January 11, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Announces Preliminary Fourth Quarter and Full Year 2023 Results and Provides 2024 Outlook
January 08, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
New research highlights the positive impact of GLP-1s and other anti-obesity medications on the Allurion Program
January 05, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion’s Digital Platform Gains Traction with Expanded Strategic Partnership
January 02, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Reports Third Quarter 2023 Financial Results and Provides Business Update
November 13, 2023
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion to Participate in the Jefferies London Healthcare Conference
November 06, 2023
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion to Report Third Quarter 2023 Financial Results on November 13, 2023
November 06, 2023
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Completes Enrollment in Pivotal AUDACITY Trial for the Allurion Balloon
October 11, 2023
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Announces Acceptance of Five Abstracts for Presentation at Obesity Week 2023
October 04, 2023
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Featured at the 2023 International Bariatric Club Oxford University World Congress
September 18, 2023
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Introduces Coach Iris: A 24/7 Generative AI-Powered Weight Loss Coach
August 29, 2023
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Announces Acceptance of Nine Scientific Presentations at IFSO 2023 World Congress
August 28, 2023
From
Allurion
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.